Latest dupixent® (dupilumab) and itepekimab data at ers highlight scientific innovation and leadership in respiratory diseases

20 abstracts, including 4 oral presentations, offer new treatment insights for chronic obstructive pulmonary disease (copd), asthma and chronic rhinosinusitis with nasal polyps (crswnp)

REGN Ratings Summary

REGN Quant Ranking